JULENE SMITH: Open Payments
NPI 1083071898 · CAIRO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 10 payments from 7 companies in 2025. Trend: 2023 $388 · 2024 $310 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: REXULTI, LYBALVI, VRAYLAR, Auvelity, CAPLYTA, MOUNJARO, INGREZZA.
Industry payments across GA — which companies pay providers there.
